Psoriasis and risk of malignant lymphoma: A population-based cohort study

M R Kamstrup; L Skov; C Zachariae; J P Thyssen; A Egeberg

doi:10.1111/bjd.16245

Psoriasis and risk of malignant lymphoma: A population-based cohort study

M R Kamstrup, L Skov, C Zachariae, J P Thyssen, A Egeberg

Dermatology and Allergy

14 Citations (Scopus)

Abstract

In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited1-4 . We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis. This article is protected by copyright. All rights reserved.

Original language	English
Journal	British Journal of Dermatology
ISSN	0007-0963
DOIs	https://doi.org/10.1111/bjd.16245
Publication status	Published - 18 Mar 2018

Keywords

Letter

Access to Document

10.1111/bjd.16245

Cite this

@article{cd202d904ab9405e8e01f6d6932aeedd,

title = "Psoriasis and risk of malignant lymphoma: A population-based cohort study",

abstract = "In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited1-4 . We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis. This article is protected by copyright. All rights reserved.",

keywords = "Letter",

author = "Kamstrup, {M R} and L Skov and C Zachariae and Thyssen, {J P} and A Egeberg",

year = "2018",

month = mar,

day = "18",

doi = "10.1111/bjd.16245",

language = "English",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Psoriasis and risk of malignant lymphoma

T2 - A population-based cohort study

AU - Kamstrup, M R

AU - Skov, L

AU - Zachariae, C

AU - Thyssen, J P

AU - Egeberg, A

PY - 2018/3/18

Y1 - 2018/3/18

N2 - In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited1-4 . We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis. This article is protected by copyright. All rights reserved.

AB - In patients with psoriasis, the risk of lymphoma has been a subject of controversy and data from larger studies are limited1-4 . We therefore investigated the 5-year risk of new-onset Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) (excluding cutaneous T-cell lymphoma [CTCL]), and CTCL, respectively, in patients with psoriasis. This article is protected by copyright. All rights reserved.

KW - Letter

U2 - 10.1111/bjd.16245

DO - 10.1111/bjd.16245

M3 - Letter

C2 - 29247449

SN - 0007-0963

JO - British Journal of Dermatology

JF - British Journal of Dermatology

ER -

Psoriasis and risk of malignant lymphoma: A population-based cohort study

Abstract

Keywords

Access to Document

Fingerprint

Cite this